United Therapeutics UTHR Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $1.56B-8.3% | $1.7B+40.5% | $1.21B+25.6% | $961.2M+7.4% | ||
| $1.36B-13.2% | $1.57B-12.1% | $1.79B-4.9% | $1.88B+81.2% | ||
| $350.2M+25.4% | $279.3M+0.1% | $278.9M+26.5% | $220.4M+10.9% | ||
| $183.1M+16.0% | $157.9M+41.2% | $111.8M+9.6% | $102M+8.7% | ||
| $3.7B-4.4% | $3.87B+9.1% | $3.55B+5.0% | $3.38B+45.5% | ||
| $1.73B+41.5% | $1.22B+16.9% | $1.05B+21.3% | $861.5M+10.3% | ||
| $116.5M+4.1% | $111.9M-2.0% | $114.2M+157% | $44.5M-0.2% | ||
| $7.88B+7.0% | $7.36B+2.7% | $7.17B+18.6% | $6.04B+16.9% | ||
| $488M+41.7% | $344.5M+15.6% | $298M+29.6% | $229.9M+31.7% | ||
| $560.6M-24.0% | $738.1M-8.2% | $804.4M+134% | $343.2M+12.4% | ||
| $783.8M-14.8% | $920M-22.2% | $1.18B-5.3% | $1.25B+3.1% | ||
| $800K0.0% | $800K+14.3% | $700K0.0% | $700K0.0% | ||
| $8.56B+18.5% | $7.22B+19.8% | $6.03B+19.5% | $5.04B+16.9% | ||
| $7.1B+10.1% | $6.44B+7.7% | $5.98B+24.8% | $4.8B+21.2% | ||
| $7.88B+7.0% | $7.36B+2.7% | $7.17B+18.6% | $6.04B+16.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are United Therapeutics's total assets?
- United Therapeutics (UTHR) holds $6.7B in total assets, down 13.3% year over year.
- How much cash does United Therapeutics have?
- United Therapeutics holds $1.3B in cash and equivalents.
- Can United Therapeutics cover its short-term obligations?
- Its current ratio is 4.79 — current assets exceed current liabilities.
- Where does United Therapeutics's balance sheet data come from?
- Every line is extracted from United Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
